Influence of a Dietary Supplement as Treatment of Migraine in Children and Adolescents
NCT ID: NCT01010711
Last Updated: 2010-02-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
76 participants
INTERVENTIONAL
2009-11-30
2011-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Combination of Coenzyme Q10, Feverfew and Magnesium for Migraine Prophylaxis : a Prospective Observational Study
NCT02901756
Migraine in Adolescents
NCT05654012
Idebenone for the Preventive Treatment of Migraine
NCT04151472
Puberty, Sex Hormones and Pain Sensitivity in Adolescents With Migraine
NCT05738213
Evaluation of Efficacy and Safety of add-on Alpha-lipoic Acid on Migraine Prophylaxis in Adolescent Population
NCT04064814
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
migraine dietary supplement
the average days of migraine during a 4 week-run-in-period are compared with the average days of migraine during intervention with a "specific dietary supplement" from week 8 - 12
Migra 3
powder containing coenzyme q10, blueberries, black current, vitamins, magnesium,trace elements
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Migra 3
powder containing coenzyme q10, blueberries, black current, vitamins, magnesium,trace elements
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* any disease that forbids the participation in the trial according to the investigators assessment
* pregnancy
* no willingness to participate in the trial
* known allergy to fish or soya
8 Years
17 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Complen Health GmbH
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
COMPLEN HEALTH GmbH
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Charly Gaul, MD
Role: PRINCIPAL_INVESTIGATOR
Universiätsklinikum Essen Neurologische Klinik, Westdeutsches Kopfschmerzzentrum, Hufelandstr.26, D-45147 Essen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universiätsklinikum Essen Neurologische Klinik, Westdeutsches Kopfschmerzzentrum, Hufelandstr.26,
Essen, North Rhine-Westphalia, Germany
Migräne und Kopfschmerzklinik Königstein
Königstein im Taunus, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TOM-DS-CH-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.